Cite

HARVARD Citation

    Gillard, P. et al. (2016). Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study. Tuberculosis. pp. 118-127. [Online]. 
  
Back to record